BackBaudax Bio Overview

Baudax Bio Goodwill

Track Baudax Bio's goodwill ($8.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$8.80M
↑ 313.59% YoYΔ $6.67M vs prior year quarter

Peer average

Loading

Baudax Bio Goodwill History

Loading

Baudax Bio vs. peers: Goodwill Comparison

Loading

Baudax Bio Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Baudax Bio (BXRXQ) FAQ

As of the most recent data (September 2023), BXRXQ shows a goodwill of $8.8M. That compares with $2.1M in the prior-year period — up 313.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BXRXQ's goodwill is now $8.8M (was $2.1M) — a 313.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Baudax Bio is outperforming or lagging.

Tracking BXRXQ's goodwill over time shows whether Baudax Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $8.8M That compares with $2.1M in the prior-year period — up 313.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Baudax Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $8.8M) with ownership activity and broader fundamentals.

Baudax Bio's goodwill is $8.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.